Showing 161 - 180 results of 201 for search '"Hartford Hospital"', query time: 0.13s Refine Results
  1. 161

    COVID-19 mortality risk assessment: An international multi-center study by Bertsimas, Dimitris J, Lukin, Galit, Mingardi, Luca, Nohadani, Omid, Orfanoudaki, Agni, Stellato, Bartolomeo, Wiberg, Holly, Gonzalez-Garcia, Sara, Parra-Calderón, Carlos Luis, Robinson, Kenneth, Schneider, Michelle, Stein, Barry, Estirado, Alberto, a Beccara, Lia, Canino, Rosario, Dal Bello, Martina, Pezzetti, Federica, Pan, Angelo, Hellenic COVID-19 Study Group

    Published 2020
    “…In the validation cohorts, the model obtains AUCs of 0.92 (95% CI, 0.88–0.95) on Seville patients, 0.87 (95% CI, 0.84–0.91) on Hellenic COVID-19 Study Group patients, and 0.81 (95% CI, 0.76–0.85) on Hartford Hospital patients. The CMR tool is available as an online application at https:/www.covidanalytics.io/mortality_calculator and is currently in clinical use. …”
    Get full text
    Article
  2. 162
  3. 163
  4. 164
  5. 165
  6. 166
  7. 167
  8. 168

    Intravenously-injected gold nanoparticles (AuNPs) access intracerebral F98 rat gliomas better than AuNPs infused directly into the tumor site by convection enhanced delivery by Smilowitz HM, Meyers A, Rahman K, Dyment NA, Sasso D, Xue C, Oliver DL, Lichtler A, Deng X, Ridwan SM, Tarmu LJ, Wu Q, Salner AL, Bulsara KR, Slatkin DN, Hainfeld JF

    Published 2018-07-01
    “…Henry M Smilowitz,1 Alexandria Meyers,1 Khalil Rahman,1 Nathaniel A Dyment,2 Dan Sasso,1 Crystal Xue,3 Douglas L Oliver,4 Alexander Lichtler,5 Xiaomeng Deng,6 Sharif M Ridwan,1 Lauren J Tarmu,7,8 Qian Wu,9 Andrew L Salner,10 Ketan R Bulsara,11 Daniel N Slatkin,12 James F Hainfeld12 1Department of Cell Biology, University of Connecticut Health Center, Farmington, CT, 2Department of Orthopedic Surgery, University of Pennsylvania, Philadelphia, PA, 3George Washington University School of Medicine, Washington, DC, 4Department of Neuroscience, University of Connecticut Health Center, Farmington, CT, 5Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, 6David Geffen School of Medicine at UCLA, Student Affairs Office, Los Angeles, CA, 7Department of Human Behavior, College of Southern Nevada, 8Department of Anthropology, University of Nevada, Las Vegas, NV, 9Department of Anatomic Pathology, University of Connecticut Health Center, Farmington, 10The Gray Cancer Center, Hartford Hospital, Hartford, 11Division of Neurosurgery, UConn Health, Farmington, CT, 12Nanoprobes, Inc, Yaphank, NY, USA Background: Intravenously (IV)-injected gold nanoparticles (AuNPs) powerfully enhance the efficacy of X-ray therapy of tumors including advanced gliomas. …”
    Get full text
    Article
  9. 169
  10. 170
  11. 171
  12. 172
  13. 173
  14. 174

    Serum Markers of Blood-Brain Barrier Remodeling and Fibrosis as Predictors of Etiology and Clinicoradiologic Outcome in Intracerebral Hemorrhage by Matthew D. Howe, Liang Zhu, Lauren H. Sansing, Nicole R. Gonzales, Louise D. McCullough, Nancy J. Edwards

    Published 2018-09-01
    “…We also hypothesized these markers may be unique in patients with ICH due to cerebral amyloid angiopathy (CAA) vs. other etiologies.Methods: Seventy-nine patients enrolled in prospective ICH registries at two separate hospitals (the University of Texas Health Science Center at Houston and Hartford Hospital) were included in this study. We assessed initial injury severity and admission variables along with measures of inpatient deterioration (hematoma expansion, perihematomal edema (PHE), and early and delayed neurologic deterioration) and functional outcome [modified Rankin Scale (mRS) score at discharge and 90 days]. …”
    Get full text
    Article
  15. 175
  16. 176
  17. 177
  18. 178
  19. 179
  20. 180